NextFerm Technologies Ltd

NXFR.MTASEIL0011719338₪25M

Investment Thesis

Generates revenue from developing and selling yeast-derived nutrition ingredients and dietary supplements, including an astaxanthin antioxidant and a yeast-based vegan protein. It also monetizes yeast strain/processing know-how through product by-products and licensing/JV commercialization.

Geographic Exposure

IsraelN/A

United StatesN/A

IndiaN/A

North MacedoniaN/A

SpainN/A

EuropeN/A

Revenue Drivers

Astaxanthin dietary supplement

Yeast-derived astaxanthin ingredient sold for supplement and functional food formats.

CORE59%

Yeast-based vegan protein ingredient

Concentrated yeast protein ingredient for sports nutrition and food formulations.

CORE40%

End Markets

Dietary supplement brands
Functional food and sports nutrition manufacturers
Plant-based meat and dairy alternative manufacturers
Infant and adult nutrition formula manufacturers
Animal feed and pet nutrition producers
Fermentation industry users (culture media inputs)

Specializations

Non-GMO yeast strain improvementFermentation scale-up (industrial scale-up)Nutritional ingredient purification and separationZero-waste by-product valorization (extract, cell walls, beta-glucan)GRAS and food-ingredient regulatory approvalsGMP-compliant subcontract manufacturing+1 more

Activities

Non-GMO yeast strain development
Fermentation process development and scale-up
Purification, cleaning and separation of nutritional components
Product commercialization via sales, subcontract manufacturing, and licensing/JVs